SELARL PHARMACIE SAUVEPLANE SALVAING : revenue, balance sheet and financial ratios

SELARL PHARMACIE SAUVEPLANE SALVAING is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BEZIERS (34500), this company of category PME shows in 2022 a revenue of 1.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE SAUVEPLANE SALVAING (SIREN 823306170)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C 1 462 454 € 1 315 335 € 1 057 704 € 743 411 € 589 737 € N/C
Net income 33 666 € 9 194 € 93 278 € 100 698 € -2 879 € -1 468 € 43 232 € 10 517 €
EBITDA N/C N/C 111 568 € 130 275 € 12 872 € 6 025 € 48 042 € N/C
Net margin N/C N/C 6.4% 7.7% -0.3% -0.2% 7.3% N/C

Revenue and income statement

In 2024, SELARL PHARMACIE SAUVEPLANE SALVAING generates positive net income of 34 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 11 k€ -> 34 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

33 666 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 107%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 35%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

106.706%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

34.548%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

40.9%

Solvency indicators evolution
SELARL PHARMACIE SAUVEPLANE SALVAING

Sector positioning

Debt ratio
106.71 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average -7 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE SAUVEPLA... (106.71) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
34.55% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +7 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE SAUVEPLA... (34.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
4.63 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average

In 2022, the repayment capacity of SELARL PHARMACIE SAUVEPLA... (4.63) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 195.49. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

195.487

Liquidity indicators evolution
SELARL PHARMACIE SAUVEPLANE SALVAING

Sector positioning

Liquidity ratio
195.49 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good

In 2024, the liquidity ratio of SELARL PHARMACIE SAUVEPLA... (195.49) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
2.49x 2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average

In 2022, the interest coverage of SELARL PHARMACIE SAUVEPLA... (2.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE SAUVEPLANE SALVAING

Positioning of SELARL PHARMACIE SAUVEPLANE SALVAING in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE SAUVEPLANE SALVAING is estimated at 470 002 € (range 327 302€ - 703 150€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
327k€ 470k€ 703k€
470 002 € Range: 327 302€ - 703 150€
NAF 5 année 2024

Valuation method used

Net Income Multiple
33 666 € × 14.0x = 470 002 €
Range: 327 302€ - 703 150€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE SAUVEPLANE SALVAING with other companies in the same sector:

Frequently asked questions about SELARL PHARMACIE SAUVEPLANE SALVAING

What is the revenue of SELARL PHARMACIE SAUVEPLANE SALVAING ?

The revenue of SELARL PHARMACIE SAUVEPLANE SALVAING in 2022 is 1.5 M€.

Is SELARL PHARMACIE SAUVEPLANE SALVAING profitable?

Yes, SELARL PHARMACIE SAUVEPLANE SALVAING generated a net profit of 34 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE SAUVEPLANE SALVAING ?

The headquarters of SELARL PHARMACIE SAUVEPLANE SALVAING is located in BEZIERS (34500), in the department Herault.

Where to find the tax return of SELARL PHARMACIE SAUVEPLANE SALVAING ?

The tax return of SELARL PHARMACIE SAUVEPLANE SALVAING is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE SAUVEPLANE SALVAING operate?

SELARL PHARMACIE SAUVEPLANE SALVAING operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.